Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what — from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 1,397 filings

Top spenders & firms Spend by issue

Clear
Q4
HIV AND HEPATITIS POLICY INSTITUTE for HIV AND HEPATITIS POLICY INSTITUTE
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Health Issues, Insurance, Pharmacy
View →
Q4
FAEGRE DRINKER BIDDLE & REATH LLP for ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP GLOBAL)
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $80,000.00 income
Health Issues, Pharmacy, Telecommunications, Consumer Issues/Safety/Products
View →
Q4
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS for AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
4th Quarter (Oct 1 - Dec 31) 2025 · Maryland · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy
View →
Q4
BABBAGE COFOUNDER for DIABETES PATIENT ADVOCACY COALITION
4th Quarter (Oct 1 - Dec 31) 2025 · Kentucky · House · Senate
Health Issues, Medicare/Medicaid, Budget/Appropriations, Pharmacy
View →
Q4
STANTON PARK GROUP for KYOWA KIRIN
4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate · $50,000.00 income
Pharmacy, Trade (domestic/foreign)
View →
Q4
HIGHMARK, INC. for HIGHMARK INC
4th Quarter (Oct 1 - Dec 31) 2025 · Pennsylvania · House · Senate
Pharmacy, Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code
View →
Q4
BRAVO GROUP for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $40,000.00 income
Pharmacy
View →
Q4
CHRISTIANACARE for CHRISTIANACARE
4th Quarter (Oct 1 - Dec 31) 2025 · Delaware · House · Senate
Pharmacy, Budget/Appropriations, Health Issues, Medicare/Medicaid
View →
Q4
FORWARD GLOBAL for QUOIN PHARMACEUTICALS, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · Virginia · House · Senate · $20,000.00 income
Medical/Disease Research/Clinical Labs, Pharmacy, Health Issues
View →
Q4
S-3 GROUP for GOODRX
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $60,000.00 income
Pharmacy, Health Issues
View →
Q4
FEDERAL HEALTH POLICY STRATEGIES for BRIGHTSPRING HEALTH SERVICES
4th Quarter (Oct 1 - Dec 31) 2025 · Kentucky · House · Senate · $80,000.00 income
Health Issues, Medicare/Medicaid, Pharmacy
View →
Q4
AARP for AARP
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Civil Rights/Civil Liberties, Health Issues, Medicare/Medicaid, Pharmacy
View →
Q4
WINNING STRATEGIES WASHINGTON for KALEO
4th Quarter (Oct 1 - Dec 31) 2025 · Virginia · House · Senate · $10,000.00 income
Health Issues, Pharmacy, Defense, Budget/Appropriations
View →
Q4
TRAVERE THERAPEUTICS for TRAVERE THERAPEUTICS
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate
Health Issues, Pharmacy, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View →
Q4
BIOGEN for BIOGEN
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Medicare/Medicaid, Pharmacy, Taxation/Internal Revenue Code, Trade (domestic/foreign)
View →
Q4
THE VOGEL GROUP for NEPHRON PHARMACEUTICALS CORPORATION
4th Quarter (Oct 1 - Dec 31) 2025 · South Carolina · $50,000.00 income
Pharmacy
View →
Q4
MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP) for MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS
4th Quarter (Oct 1 - Dec 31) 2025 · Texas · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy, Manufacturing
View →
Q4
STUMPTOWN STRATEGIES for PRIME THERAPEUTICS
4th Quarter (Oct 1 - Dec 31) 2025 · Minnesota · House · Senate · $20,000.00 income
Health Issues, Pharmacy
View →
Q4
NORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC for MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMER
4th Quarter (Oct 1 - Dec 31) 2025 · Texas · House · Senate · $30,000.00 income
Health Issues, Medicare/Medicaid, Pharmacy, Manufacturing
View →
Q4
CAPITOL COUNSEL LLC for EMD SERONO, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $50,000.00 income
Medicare/Medicaid, Pharmacy
View →
Q4
CONTINENTAL STRATEGY, LLC for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $135,000.00 income
Health Issues, Pharmacy
View →
Q4
CONTINENTAL STRATEGY, LLC for NRX PHARMACEUTICALS
4th Quarter (Oct 1 - Dec 31) 2025 · Delaware · $75,000.00 income
Pharmacy
View →
4T
FOLEY & LARDNER LLP for ENDO USA, INC., A MALLINCKRODT-ENDO COMPANY
4th Quarter (Oct 1 - Dec 31) 2025 · Pennsylvania · House · Senate · $20,000.00 income
Health Issues, Pharmacy
View →
Q4
BCBSM, INC. for BCBSM INC
4th Quarter (Oct 1 - Dec 31) 2025 · Minnesota · House · Senate
Health Issues, Budget/Appropriations, Pharmacy
View →
Q4
NATIONAL GROCERS ASSOCIATION for NATIONAL GROCERS ASSOCIATION
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Banking, Taxation/Internal Revenue Code, Agriculture, Labor Issues/Antitrust/Workplace
View →
Previous Page 8 of 56 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem